Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Drugs for Treatment of Diarrhea-Predominant IBS01:17

Drugs for Treatment of Diarrhea-Predominant IBS

898
Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
898
Inflammatory Bowel Disease IV: Pharmacological Management01:29

Inflammatory Bowel Disease IV: Pharmacological Management

955
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
955
Peptic Ulcer Disease IV: Management01:26

Peptic Ulcer Disease IV: Management

653
Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
653
Irritable Bowel Syndrome III: Medical and Nursing Management01:30

Irritable Bowel Syndrome III: Medical and Nursing Management

997
Managing Irritable Bowel Syndrome (IBS) involves a multifaceted approach, including lifestyle modifications, dietary changes, and medication.
997
Inflammatory Bowel Disease V: Surgical Management01:21

Inflammatory Bowel Disease V: Surgical Management

854
Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
854
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

1.1K
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
1.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

EXPRESS: Factors associated with antimicrobial drug prescription in cats receiving outpatient care at a veterinary teaching hospital.

Journal of feline medicine and surgery·2026
Same author

Rethinking How We Provide Guidance When Evidence is Limited.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2026
Same author

Infectious Diseases Society of America (IDSA) position statement: why IDSA did not endorse the community-acquired pneumonia guidelines 2025 update.

American journal of respiratory and critical care medicine·2026
Same author

A Public Health Approach to Antimicrobial Stewardship in Long-Term Care Facilities: A Multifaceted Program in Massachusetts.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2026
Same author

Infectious Diseases Society of America (IDSA) Position Statement: Why IDSA Did Not Endorse the Community-Acquired Pneumonia Guidelines 2025 Update.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2025
Same author

Nowcasting epidemic trends using hospital- and community-based virologic test data.

Nature communications·2025

Related Experiment Video

Updated: Apr 6, 2026

Fecal Microbiota Transplantation via Colonoscopy for Recurrent C. difficile Infection
07:06

Fecal Microbiota Transplantation via Colonoscopy for Recurrent C. difficile Infection

Published on: December 8, 2014

27.8K

Clostridium difficile Diarrhea in the Elderly: Current Issues and Management Options.

Masako Mizusawa1, Shira Doron, Sherwood Gorbach

  • 1Tufts Medical Center, 800 Washington Street, Boston, MA, 02111, USA, MMizusawa@tuftsmedicalcenter.org.

Drugs & Aging
|August 3, 2015
PubMed
Summary

Clostridium difficile infection (CDI) significantly impacts the elderly, with advanced age being a major risk factor. Effective management requires timely diagnosis, tailored treatment, and stringent infection control to reduce recurrence and mortality.

More Related Videos

A Protocol to Characterize the Morphological Changes of Clostridium difficile in Response to Antibiotic Treatment
12:58

A Protocol to Characterize the Morphological Changes of Clostridium difficile in Response to Antibiotic Treatment

Published on: May 25, 2017

9.5K
Culturing and Maintaining Clostridium difficile in an Anaerobic Environment
11:13

Culturing and Maintaining Clostridium difficile in an Anaerobic Environment

Published on: September 14, 2013

40.4K

Related Experiment Videos

Last Updated: Apr 6, 2026

Fecal Microbiota Transplantation via Colonoscopy for Recurrent C. difficile Infection
07:06

Fecal Microbiota Transplantation via Colonoscopy for Recurrent C. difficile Infection

Published on: December 8, 2014

27.8K
A Protocol to Characterize the Morphological Changes of Clostridium difficile in Response to Antibiotic Treatment
12:58

A Protocol to Characterize the Morphological Changes of Clostridium difficile in Response to Antibiotic Treatment

Published on: May 25, 2017

9.5K
Culturing and Maintaining Clostridium difficile in an Anaerobic Environment
11:13

Culturing and Maintaining Clostridium difficile in an Anaerobic Environment

Published on: September 14, 2013

40.4K

Area of Science:

  • Infectious Diseases
  • Gastroenterology
  • Geriatrics

Background:

  • Clostridium difficile infection (CDI) is a leading cause of healthcare-associated infectious diarrhea.
  • Advanced age is a significant risk factor for CDI development, recurrence, and mortality, exacerbated by frequent healthcare exposure and comorbidities.
  • Diagnosis relies on symptomatic patients with positive stool tests for C. difficile toxin or organism.

Purpose of the Study:

  • To review the epidemiology, risk factors, diagnosis, treatment, and prevention of CDI, with a focus on the elderly population.
  • To highlight the challenges and best practices in managing CDI in older adults.
  • To emphasize the importance of infection control measures in healthcare settings.

Main Methods:

  • Literature review of studies on Clostridium difficile infection, focusing on elderly patients.
  • Analysis of diagnostic criteria, treatment guidelines, and infection control strategies.
  • Synthesis of current therapeutic options including antibiotics and fecal microbiota transplantation.

Main Results:

  • Elderly patients face a higher burden of CDI due to factors like altered microbiota and comorbidities.
  • Antibiotic discontinuation can resolve CDI in some cases; treatment selection depends on severity and recurrence history.
  • Fecal microbiota transplantation is effective for recurrent CDI, with specific precautions for certain patient groups.
  • Strict adherence to isolation and environmental disinfection is crucial for preventing CDI transmission.

Conclusions:

  • Timely diagnosis and appropriate, severity-based treatment are essential for managing CDI in the elderly.
  • Effective infection control, including isolation and disinfection, is critical to curb CDI spread.
  • Preventing CDI recurrence and mortality in older adults requires a multi-faceted approach encompassing clinical and public health strategies.